Progress on the mechanism and application of hyperbaric oxygen therapy for neurodegenerative diseases.
- Author:
Fang-Fang WANG
1
;
Nan WANG
1
;
Heng-Rong YUAN
1
;
Ji XU
1
;
Jun MA
1
;
Xiao-Chen BAO
1
;
Yi-Qun FANG
1
Author Information
- Publication Type:English Abstract
- MeSH: Hyperbaric Oxygenation; Humans; Neurodegenerative Diseases/physiopathology*; Animals; Oxidative Stress; Apoptosis; Mitochondria/physiology*; Neurogenesis; Epigenesis, Genetic
- From: Acta Physiologica Sinica 2025;77(2):318-326
- CountryChina
- Language:Chinese
- Abstract: In 2040, neurodegenerative diseases (NDD) will overtake cancer as the second leading cause of death after cardiovascular and cerebrovascular diseases. Therefore, the search for effective intervention measures has become the top priority to deal with this difficult burden. Hyperbaric oxygen therapy (HBOT) has been used for the past 50 years to treat conditions such as decompression sickness, carbon monoxide poisoning and radiation damage. In recent years, studies have confirmed that HBOT has good effects in improving cognitive impairment after brain injury and stroke, and alleviating neurodegeneration and dysfunction related to NDD. Here we reviewed the pathogenesis and treatment state of NDD, introduced the application of HBOT in animal models and clinical studies of NDD, and expounded the application potential of HBOT in the treatment of NDD from the perspective of mitochondrial function, neuroinflammation, neurogenesis and angiogenesis, oxidative stress, apoptosis, microcirculation and epigenetics.
